Ways2Capital Equity Tips : Strides Pharma Wipes Losses, Up 3.4% As JV Gets US FDA Nod For Tapeworm Infection Drug

Shares of Strides Pharma Science rose as much as 3.4 percent after the company’s joint venture received the US FDA’s approval for its tapeworm infection treatment drug. The joint venture — Strides Vivimed — received approval from the US Food and Drug Administration… Continue Reading

WaysCapital Stock Update : Aurobindo Pharma Extends Losses On Report Of a Lawsuit Against The Co In US

Aurobindo Pharma shares fell 5.6 percent intraday Thursday on top of 3 percent loss seen in previous session after a media report indicated that the company named in a lawsuit for selling adulterated irbesartan products. The Hyderabad-based drug major has been… Continue Reading

Ways2Capital Opening Bell

 NIFTY – Previous Close : 10,656.20 OPEN @ 10,670.95(+14.75) SENSEX – Previous Close : 35,474.51 OPEN @ 35,492.62 (+18.11) BANK NIFTY – Previous Close : 26,113.35 OPEN @ : 26,105.45(-7.90)    For Quick Trial – 8962000225 ✔ or mail us here: info@ways2capital.com or visit http://www.ways2capital.com ✆ – 0731-6626191 | Toll Free – 1800-3010-2007 Give a Missed Call for… Continue Reading

Ways2Capital Stock Update : Alembic Pharmaceuticals Up 2% On USFDA Approval

Share price of Alembic Pharmaceuticals added more than 2 percent intraday Tuesday after company received USFDA approval. The company has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Vardenafil Hydrochloride Orally Disintegrating Tablets,… Continue Reading